Detalhe da pesquisa
1.
Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform.
Acta Oncol
; 56(8): 1081-1088, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28534430
2.
Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Curr Oncol
; 30(8): 7489-7498, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623023
3.
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques.
J Clin Med
; 11(23)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36498488
4.
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Radiother Oncol
; 168: 113-120, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033602
5.
AIRO Breast Cancer Group Best Clinical Practice 2022 Update.
Tumori
; 108(2_suppl): 1-144, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112842
6.
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review.
Cancer Treat Rev
; 99: 102236, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126314
7.
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study.
Br J Radiol
; 94(1123): 20201177, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882239
8.
Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
Tumori
; 96(4): 577-81, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20968137
9.
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial.
Prostate Cancer Prostatic Dis
; 21(2): 269-276, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520019